ArticleOncotarget2018

MAGE-A11 is activated through TFCP2/ZEB1 binding sites de-methylation as well as histone modification and facilitates ESCC tumor growth.

Shina Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.